Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-103.96%
operating margin TTM
-91.87%
revenue TTM
41.39 Million
revenue per share TTM
0.37$
valuation ratios | |
|---|---|
| pe ratio | -0.05 |
| peg ratio | -0.00 |
| price to book ratio | 0.05 |
| price to sales ratio | 0.06 |
| enterprise value multiple | 0.27 |
| price fair value | 0.05 |
profitability ratios | |
|---|---|
| gross profit margin | 80.98% |
| operating profit margin | -91.87% |
| pretax profit margin | -104.0% |
| net profit margin | -103.96% |
| return on assets | -40.22% |
| return on equity | -80.88% |
| return on capital employed | -41.99% |
liquidity ratio | |
|---|---|
| current ratio | 2.89 |
| quick ratio | 2.85 |
| cash ratio | 2.26 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 30.26 |
| operating cycle | 52.51 |
| days of payables outstanding | 92.91 |
| cash conversion cycle | -40.40 |
| receivables turnover | 16.40 |
| payables turnover | 3.93 |
| inventory turnover | 12.06 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.45 |
| debt equity ratio | 1.13 |
| long term debt to capitalization | 0.52 |
| total debt to capitalization | 0.53 |
| interest coverage | -14.69 |
| cash flow to debt ratio | -0.66 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.43 |
| cash per share | 0.50 |
| operating cash flow per share | -0.42 |
| free cash flow operating cash flow ratio | 1.02 |
| cash flow coverage ratios | -0.66 |
| short term coverage ratios | -20.14 |
| capital expenditure coverage ratio | -50.28 |
Frequently Asked Questions
When was the last time RVL Pharmaceuticals plc (NASDAQ:RVLP) reported earnings?
RVL Pharmaceuticals plc (RVLP) published its most recent earnings results on 14-08-2023.
What is RVL Pharmaceuticals plc's current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. RVL Pharmaceuticals plc (NASDAQ:RVLP)'s trailing twelve months ROE is -80.88%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. RVL Pharmaceuticals plc (RVLP) currently has a ROA of -40.22%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did RVLP's net profit margin stand at?
RVLP reported a profit margin of -103.96% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is RVLP's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.89 in the most recent quarter. The quick ratio stood at 2.85, with a Debt/Eq ratio of 1.13.